Outcomes of Polish response teams treating sudden blood clots in the lungs
Describes care and results for adults with acute pulmonary embolism treated by Polish specialist teams.
Key facts
- Who runs it
- Poznan University of Medical Sciences
- Where
- Poland1 site in 1 countryChoose a country to see its sites
- Trial code
- Registry title
- Polish Multicenter PERTs PE Outcomes Registry
- Status
- Recruiting
- People taking part
- 10,000 people, planned
- Started
- 1 Jun 2018
- Expected to end
- Dec 2030
- Type of study
- Observational, 2 groups
- Record updated
- 10 May 2021
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults with a sudden blood clot in the lungs (acute pulmonary embolism) treated by Polish PE response teams. It records how they are treated and how they do.
- Age
- 18 Years and older
- Sex
- All
- Disease stage
- PE confirmed by computed tomography pulmonary angiography, with symptoms for ≤ 14 days. It must be high-risk PE with unstable blood pressure or circulation (cardiac arrest, obstructive shock or persistent low blood pressure), or intermediate-high risk PE.
- Biomarker or test result
- For intermediate-high risk PE: strain of the right side of the heart seen on imaging and a raised troponin level in the blood.
Main reasons for not taking part
- Refusing to sign the informed consent form
The registry criteria, word for word
Show all 5 criteriaShow less
Who can take part
- PE confirmed by computed tomography pulmonary angiography
- PE symptoms duration ≤ 14 days
- High-risk PE with hemodynamic instability (one of):; cardiac arrest; obstructive shock; persistent hypotension
- Intermediate-high risk PE patients with right ventricle dysfunction confirmed by imaging studies and elevated troponin level
Who cannot take part
- Refusal to sign the informed consent form
This trial is currently available in Poland.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
Pulmonary embolism (PE) is the third leading cause of cardiovascular mortality. The Pulmonary Embolism Response Team (PERT) concept offers a rapid and multidisciplinary approach focused on improving outcomes for patients with PE. All institutionalized PERTs in Poland have been invited to join the study. The goal of this registry is to describe current practice and outcomes in patients with acute PE treated by Polish PERTs.
The 2 groups in the trial
- Intermediate-high risk PE
Confirmed PE causing right ventricle dysfunction confirmed by computed tomography pulmonary angiography or transthoracic echocardiography and elevated troponin level
- High-risk PE
Confirmed PE causing hemodynamic instability: 1. Cardiac arrest (need for cardiopulmonary resuscitation) or, 2. Obstructive shock (systolic blood pressure \< 90 mmHg or vasopressors required to achieve a systolic blood pressure ≥90 mmHg despite adequate filling status and end-organ hypoperfusion), or 3. Persistent hypotension (systolic blood pressure \< 90 mmHg for at least 15 minutes)
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Polish Multicenter Pulmonary Embolism Response Teams Outcomes Registry
- Plain-language title
- Outcomes of Polish response teams treating sudden blood clots in the lungsGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 15 November 2026.
- Publications
- Record updated
- 10 May 2021